COVID19 vaccination in adults with sickle cell disease is not associated with increases in rates of pain crisis

Elana Friedmana Albert Einstein College of Medicine, Bronx, NY, USACorrespondence[email protected]
View further author information

References

Singh A, et al. COVID-19 in individuals with sickle cell disease/trait compared with other Black individuals. Blood Adv. 2021. doi:10.1182/bloodadvances.2020003741.
Google Scholar
COVID-19 and sickle cell disease: frequently asked questions. 2021. https://www.hematology.org/covid-19/covid-19-and-sickle-cell-disease.
Google Scholar
Jan H, et al. COVID-19 vaccine perception and hesitancy among patients with sickle cell disease in the Western Region of Saudi Arabia. Cureus. 2022;14(1):e21026. doi:10.7759/cureus.21026.
PubMed Web of Science ®Google Scholar
Merkeley H, et al. COVID vaccination rates in children and adults with sickle cell disease in British Columbia, Canada. Blood. 2021;138(Suppl 1):3034–3034. doi:10.1182/blood-2021-152141.
Google Scholar
Nader E, et al. The red blood cell—inflammation vicious circle in sickle cell disease. Front Immunol. 2020;11. doi:10.3389/fimmu.2020.00454.
Web of Science ®Google Scholar
Alkindi S, et al. Safety warning for Chadox1 NCov-19 vaccine in patients with sickle cell disease. Mediterr J Hematol Infect Dis. 2021;13(1). doi:10.4084/mjhid.2021.059.
Google Scholar
Jeong J, Choi HS. Sudden sensorineural hearing loss after Covid-19 vaccination. Int J Infect Dis. 2021;113:341–343. doi:10.1016/j.ijid.2021.10.025.
PubMed Web of Science ®Google Scholar